Trials Sponsors Conditions Drugs Pricing

Conditions

Breech Presentation of Fetus With Successful Version

Outcome Measures

Primary Outcomes (1)

External cephalic version success
The rate of successful external cephalic version
Up to 10 minutes from the beginning of external cephalic version.

Secondary Outcomes (4)

Pain
Up to 2 hours from the beginning of external cephalic version.
Placental abruption
Up to 1 week from the beginning of external cephalic version.
Vaginal delivery
Up to 4 weeks from the beginning of external cephalic version.
Cesarean delivery
Up to 4 weeks from the beginning of external cephalic version.

Study Arms (2)

Trendelenburg

ACTIVE COMPARATOR

Women positioned in the trendelenburg position during external cephalic version.

Other: Trendelenburg positioning

Control

NO INTERVENTION

Women positioned on their back during external cephalic version.

Interventions

Trendelenburg positioningOther

Women positioned in the trendelenburg position prior to external cephalic version

Trendelenburg

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 45 Years

Sexfemale(Gender-based eligibility)

Gender Eligibility DetailsFemale

Healthy VolunteersNo

Age GroupsAdult (18-64)

You may qualify if:

Women interested in having external cephalic version at a gestational age of 37+0/7 or more.

You may not qualify if:

Sponsors & Collaborators

Rambam Health Care Campus
Otherlead

Study Sites (1)

Rambam health care campus

Haifa, Israel

RECRUITING

Roy Lauterbach, MDCONTACT0529432416 r_lauterbach@rambam.health.gov.il

MeSH Terms

Interventions

Head-Down Tilt

Intervention Hierarchy (Ancestors)

PostureMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

Roy Lauterbach, MD
Rambam healthcare campus
PRINCIPAL INVESTIGATOR

Central Study Contacts

Roy Lauterbach, MD

CONTACT

+972-52-9432416 r_lauterbach@rmc.gov.il

Study Design

Study Type: interventional
Phase: not applicable
Allocation: RANDOMIZED
Masking: NONE
Purpose: TREATMENT
Intervention Model: PARALLEL
Sponsor Type: OTHER
Responsible Party: PRINCIPAL INVESTIGATOR
PI Title: Principal Investigator

Study Record Dates

First Submitted

October 6, 2020

First Posted

October 14, 2020

Study Start

November 1, 2020

Actual (reported)

Primary Completion

September 30, 2023

Estimated (date passed)

Trendelenburg Positioning and External Cephalic Version Outcome

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (2)

Trendelenburg

Control

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (4)

Study Arms (2)

Trendelenburg

Control

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Central Study Contacts

Study Design

Study Record Dates

Data Sharing

Source record

Locations